Related Experiment Video
Updated: Aug 6, 2026
06:46
Caudal-to-cranial Approach in Laparoscopic Right Hemicolectomy with Complete Mesocolon Excision and D3 Lymph Node Dissection
Published on: January 9, 2026
Laparoscopic-assisted colectomy for colon cancer
Maureen M Tedesco1, Myriam J Curet
1Stanford University School of Medicine, Department of Surgery, Stanford, CA 94305-5655, USA.
Expert Review of Medical Devices
|July 27, 2006
Summary
Laparoscopic-assisted colectomy (LAC) for colon cancer offers comparable oncological outcomes to open surgery. Patients experience significant benefits, including faster recovery and shorter hospital stays with LAC.
Area of Science:
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Laparoscopic-assisted colectomy (LAC) for colon cancer, introduced in 1991, faced slow adoption compared to procedures for benign conditions.
- Concerns regarding oncological safety and efficacy historically limited LAC acceptance in colon cancer treatment.
Purpose of the Study:
- To evaluate the oncological safety and patient benefits of laparoscopic-assisted colectomy (LAC) for colon cancer.
- To compare LAC outcomes with traditional open colectomy in colon cancer patients.
Main Methods:
- Review of recent large, randomized controlled trials comparing LAC with open colectomy for colon cancer.
- Analysis of oncological endpoints including survival, port-site metastases, and tumor recurrence.
- Assessment of patient-reported outcomes and recovery metrics.
Main Results:
- LAC demonstrates oncological outcomes comparable to open colectomy regarding survival, port-site metastases, and tumor recurrence.
- Patients undergoing LAC show significant advantages in reduced analgesic use, faster return of bowel function, shorter hospital stays, and quicker return to normal activities.
Conclusions:
- Laparoscopic-assisted colectomy is a safe and effective oncological treatment for colon cancer.
- LAC offers substantial patient benefits, making it a favorable alternative to open colectomy for selected colon cancer patients.
